0.7873

3.24% -0.0264

Beyondspring Inc (BYSI)

Überblick Nachrichten Preisverlauf Optionskette Forum Prognose

Schlusskurs vom Vortag:

$0.8137

Offen:

$0.788925

24-Stunden-Volumen:

65,271

Relative Volume:

0.08

Marktkapitalisierung:

$32.37M

Einnahmen:

$1.88M

Nettoeinkommen (Verlust:

$-8.48M

KGV:

-4.1855

EPS:

-0.1881

Netto-Cashflow:

$-19.13M

1W Leistung:

+1.30%

1M Leistung:

+28.85%

6M Leistung:

-54.36%

1J Leistung:

-54.49%

1-Tages-Spanne:

$0.7842

$0.8494

1-Wochen-Bereich:

$0.57

$1.14

52-Wochen-Spanne:

$0.5657

$2.44

Beyondspring Inc Stock (BYSI) Company Profile

Firmenname

Beyondspring Inc

Sektor

Healthcare (1064)

Branche

Biotechnology (595)

Telefon

646-528-4184

Adresse

100 CAMPUS DRIVE, WEST SIDE, 4TH FLOOR, FLORHAM PARK, NY

Mitarbeiter

Twitter

@BeyondSpringInc

Nächster Verdiensttermin

2026-11-11

Neueste SEC-Einreichungen

BYSI's Discussions on Twitter

Compare BYSI vs VRTX, MRNA, REGN, ARGX, RVMD

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
BYSI Beyondspring Inc	0.7873	31.96M	1.88M	-8.48M	-19.13M	-0.1881
VRTX Vertex Pharmaceuticals Inc	504.73	133.37B	12.34B	4.34B	3.71B	16.87
MRNA Moderna Inc	190.01	79.40B	2.23B	-3.19B	-1.60B	-8.1462
REGN Regeneron Pharmaceuticals Inc	735.20	81.13B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	919.21	60.03B	4.16B	1.29B	734.26M	19.58
RVMD Revolution Medicines Inc	206.64	43.93B	742.00K	-1.37B	-1.07B	-7.0731

Beyondspring Inc Stock (BYSI) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2021-12-02	Herabstufung	BofA Securities	Buy → Underperform
2021-12-02	Herabstufung	Jefferies	Buy → Hold
2021-12-01	Herabstufung	H.C. Wainwright	Buy → Neutral
2021-12-01	Herabstufung	William Blair	Outperform → Mkt Perform
2021-09-09	Eingeleitet	Robert W. Baird	Outperform
2021-08-04	Hochstufung	H.C. Wainwright	Neutral → Buy
2021-04-05	Herabstufung	H.C. Wainwright	Buy → Neutral
2021-01-11	Eingeleitet	BofA Securities	Buy
2020-12-29	Eingeleitet	Evercore ISI	Outperform
2020-02-07	Eingeleitet	Jefferies	Buy
2020-01-10	Eingeleitet	Nomura	Buy
2019-12-03	Eingeleitet	William Blair	Outperform
2019-07-10	Bestätigt	H.C. Wainwright	Buy
2019-04-30	Herabstufung	Maxim Group	Buy → Hold
2018-10-25	Bestätigt	Maxim Group	Buy

Alle ansehen

Beyondspring Inc Aktie (BYSI) Neueste Nachrichten

Sep 29, 2026

BeyondSpring Inc. Announces FDA Fast Track Designation For Plinabulin And Docetaxel In Post-ICI Non-Squamous NSCLC - marketscreener.com

Sep 29, 2026

BYSI Forecast — Price Target — Prediction for 2027 - TradingView

Sep 29, 2026

'Beyond Spring and Fall': Apple Prepares Organization Restructure for Accelerating Product Launches - TradingView

Sep 29, 2026

BeyondSpring Receives FDA Fast Track for Plinabulin - grafa.com

Sep 29, 2026

Form 8K BeyondSpring Inc For: 29 September By Investing.com - Investing.com Nigeria

Sep 29, 2026

BeyondSpring Secures FDA Fast Track Designation for Plinabulin as DUBLIN-4 Phase 3 Trial Advances - Yahoo Finance

Sep 29, 2026

Form 424B5 BeyondSpring Inc For: 29 September By Investing.com - Investing.com Nigeria

Sep 29, 2026

BeyondSpring launches ATM program to bolster financing - TipRanks

Sep 29, 2026

FDA grants fast track status to BeyondSpring’s lung cancer drug - Investing.com

Sep 29, 2026

Beyondspring Inc Entered Into Open Market Sale Agreement Under Which Co May Offer And Sell Up To 9.2 Million Ordinary Shares - TradingView

Sep 29, 2026

About 221 patients are expected to enroll in China, with an investor helping fund the lung cancer trial. - Stock Titan

Sep 29, 2026

BeyondSpring Announces FDA Fast Track Designation for - GlobeNewswire

Sep 29, 2026

Sep 24, 2026